Table 3 Treatment response according to IL28B genotype in different HCV genotypes
Genotype | SVR | NVR | REL | P value | NVR vs. SVR | Rel vs. SVR |
|---|---|---|---|---|---|---|
N,% | N,% | N,% | OR(95%CI) | OR(95%CI) | ||
Non-G1 | 73(66.4%) | 18(16.3%) | 19(17.3%) | 1.0 (Reference) | 1.0 (Reference) | |
TT | 60(77.9%) | 7(9.1%) | 10(13.0%) | <0.001 | ||
TG+GG | 13(39.4%) | 11(33.3%) | 9(27.3%) | |||
G1 | 58(46.0%) | 29(23.0%) | 39(31.0%) | 2.03(1.03–4.01) | 2.58(1.35–4.94) | |
TT | 26(60.5%) | 3(7.0%) | 14(32.6%) | 0.006 | ||
TG+GG | 32(38.6%) | 26(31.3%) | 25(30.1%) |